Form 4 for CTSO Cytosorbents Corp
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-18 · accession 0001104659-22-062697 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-19 | 2022-05-18 | CTSO | BATOR MICHAEL G. | Dir | P - Purchase | $2.19 | +11.0K | 83.8K | +15% | +$24.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-18 | P | A | 1,000 | $2.21 | 84,800 | D | — | — | (F1) Includes (a) the following restricted stock units which will vest upon a "Change of Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, and (iii) 60,000 restricted stock units granted on June 7, 2017, and (b) 15,500 shares of common stock owned by the reporting person, inclusive of 11,000 total shares of common stock purchased on May 18, 2022 and reported on this Form 4. |
| 2 | Common | Common Stock | 2022-05-18 | P | A | 2,000 | $2.20 | 81,800 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-18 | P | A | 2,000 | $2.20 | 79,800 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-18 | P | A | 2,000 | $2.18 | 77,800 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-18 | P | A | 2,000 | $2.18 | 75,800 | D | — | — | |
| 6 | Common | Common Stock | 2022-05-18 | P | A | 2,000 | $2.20 | 83,800 | D | — | — |